Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Acute Ischemic Stroke and the Subsequent Risk for Poor Functional Outcomes/Experiment 6

From BugSigDB


Reviewed Marked as Reviewed by Folakunmi on 2024-11-13

Curated date: 2024/10/27

Curator: InimfonD

Revision editor(s): InimfonD, Rahila, MyleeeA

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Stroke outcome severity measurement Stroke outcome severity measurement,stroke outcome severity measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Moderate Acute ischemic stroke (AIS)
Group 1 name Corresponds to the case (exposed) group for case-control studies
Mild (AIS)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Acute ischemic stroke Patients with National Institutes of Health Stroke Scale (NIHSS) score < 5 points
Group 0 sample size Number of subjects in the control (unexposed) group
47
Group 1 sample size Number of subjects in the case (exposed) group
78
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
No antibiotics, prebiotics or probiotics taken in the past 3 months.

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2.5


Signature 1

Reviewed Marked as Reviewed by Folakunmi on 2024-11-13

Curated date: 2024/10/27

Curator: InimfonD

Revision editor(s): InimfonD, Rahila, MyleeeA

Source: Figure 3

Description: Comparison of the abundance of short-chain fatty acid-producing gut microbiota between moderate and mild acute ischemic patients according to taxonomic classification and LEfSe analysis.

Abundance in Group 1: increased abundance in Mild (AIS)

NCBI Quality ControlLinks
Roseburia

Revision editor(s): InimfonD, Rahila, MyleeeA

Signature 2

Reviewed Marked as Reviewed by Folakunmi on 2024-11-13

Curated date: 2024/10/27

Curator: InimfonD

Revision editor(s): InimfonD, Rahila, MyleeeA

Source: Figure 3

Description: Comparison of the abundance of short-chain fatty acid-producing gut microbiota between moderate and mild acute ischemic patients according to taxonomic classification and LEfSe analysis.

Abundance in Group 1: decreased abundance in Mild (AIS)

NCBI Quality ControlLinks
Akkermansia

Revision editor(s): InimfonD, Rahila, MyleeeA